Gyre Therapeutics Inc (GYRE)

SBC to Revenue

7.13%

Quarterly · Period ending:

GYRE logo

GYRE SBC to Revenue

Latest reported7.13%
GYRE Quarterly SBC/Revenue (0.00% → 7.13%)
High-resolution chart · PNG

GYRE sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
7.1294%
0%
12.3592%
3.7528%
3.047%
2.2985%
2.0343%
0%
0%
0.0405%
26.8197%
0%
0%
0%
0%
0%
0%
80.7248%
0%
31.0135%
86.8375%
69.9387%
0%
119.5969%
50.3016%
4.9187%
0%
0%
0%
0%
-12,333.3333%
0%
0%
10,100%
96.5409%
102.2013%
100%
44.2804%
183.0986%
171.5596%
151.3761%
140.367%
175.2294%
-1,312.844%
81.0244%
129.2719%
51.3514%
3,228%
2,736.1111%
948.2759%
1,138.7097%
0%
0%
45.6448%
233.5593%
187.5%
9.2495%
8.3826%
10.5674%
11.3321%
10.606%
5.547%
5.2522%
5.6198%
5.9372%
6.3377%
22.0245%
4.3671%
20.2473%
9.3307%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.